PhD opportunities with Monash Partners

Monash Partners has 2 PhD opportunities:

• Consumer and Community Involvement Implementation Research for Impact
• Strengthening trust and engagement with populations at risk of COVID-19 and other diseases

The COVID PhD is in partnership with the Victorian Department of Health in the pilot of a translational research PhD fellowship program; $23,000 top-up funding will be provided per student per year for 3 years.  

Monash Partners update

Professor Helena Teede,
Executive Director, Monash Partners

Read all the latest Monash Parners updates here:

http://mailchi.mp/0e8c765be57f/monash-partners-update-july-246193

Monash Partners Free Good Clinical Practice Course for Researchers

From August 2016, Monash University will offer TransCelerate accredited ICH Good Clinical Practice Training in clinical research, expected and recognised by pharmaceutical companies in commercially-sponsored clinical trials.

ICH GCP is also increasingly a requirement of human research and ethics committees.

Training is available to all paid employees of the Monash Partners organisations, funded by the Partners at no cost to attendees. It is offered at two sites: the Alfred Medical Research and Education Precinct (AMREP) and the Monash Health Translation Precinct (MHTP). Subject to demand, training may also be available at other Monash Partners sites.

The training program is delivered by trained GCP facilitators with extensive experience in clinical research and consists of:

ICH GCP Training: a 5 hour face to face interactive workshop, designed for those involved in pharma or clinical research, including Principal Investigators, Associate Investigator and Clinical Trial Coordinator responsibilities.

The course consists of five modules: The Standards, Study Set Up, Informed Consent, Case Report Form and Data Entry, Safety Reporting.

Refresher ICH GCP: a 2 hour face to face workshop, available from September 2016. Information about eligibility for this program will be available on the website.

National recognition for Monash Partners: One of Australia's first Academic Health Research and Translation Centres

Prof Christina Mitchell

Monash Partners is officially recognised as one only four Advanced Health Research and Translation Centres (AHRTCs) in Australia, acknowledging the collaboration’s capability to improve health outcomes through high impact translational research.

In an announcement made by the Minister for Health, the Hon Sussan Ley MP and the National Health and Medical Research Council (NHMRC) on Saturday, the Monash Partners Academic Health Science Centre was recognised as an international leader in linking clinical practice, research translation and education.

An innovative collaboration established in 2013, Monash Partners’ members include Monash University, Monash Health, Alfred Health, Cabrini Health, Epworth Healthcare, Baker IDI, Burnet Institute and MIMR-PHI Institute.

“This recognition will significantly enhance our capabilities as a collaborative clinical and research leader and innovator,” said Monash Partners’ Chair and Dean of the Faculty of Medicine, Nursing and Health Sciences at Monash University, Professor Christina Mitchell.

New international partnership leads to collaborative translational research in pregnancy health

Prof Euan Wallace

Improved pregnancy health is the aim of an international translational research collaboration at The Ritchie Centre.

The Ritchie Centre has received a grant for the development of a Pregnancy Research Synergy between Monash and Manchester Maternal and Fetal Health Research Centre (MFHRC).   This follows the 2014 launch of the joint Monash Partners and Manchester Academic Health Science Centre Seed funding round.

The Ritchie Centre and MFHRC will explore their current research programmes overlap to determine potential for collaborative translational research with the goal of improving pregnancy health for mothers in Victoria, Greater Manchester and beyond.

Professor Euan Wallace, Head of Department of Obstetrics and Gynaecology and Director of The Ritchie Centre said, “We are very excited about this two-way collaboration, with our complimentary expertise we can accelerate clinical application of discovery science.”

The first synergy project will involve both parties exploring a clinical trial into preeclampsia. This collaborative study is an extension of the pre-existing research into preeclampsia but looking for new treatments and fast tracking research insights.

 “Once the pilot study is complete we will have developed a streamlined pathway that will allow translational animal studies in pregnancy disease to be carried out jointly at both sites.”

The funding will enable both groups to come together for a series of face-to-face meetings, with the first to take place later this year in Brisbane.

“Both The Ritchie Centre and MFHRC have a similar structure, with a dynamic research group integrated into a major hospital,” added Professor Wallace. 

“By working together in close collaboration we can expand the number of our experimental trials and accelerate their translation to the patients beside, helping us to achieve a reduction in preventable stillbirth.”